Pfizer Inc (PFE)
41.36
-0.11 -0.27%
NYSE
May 20, 15:11
Delayed 2m
USD
View All Key Stats
PFE Key Stats
| Income Statement | |
| Revenue (TTM) | 53.86B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.95 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 11.48B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 81.45% |
| Profit Margin (Quarterly) | 29.61% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 229.96B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 4.531 |
| PE Ratio (TTM) | 21.21 |
| Price to Book Value | 3.912 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.08B |
| Return on Equity (TTM) | Upgrade |
View All PFE News
PFE News
-
WireHeadlineTime (ET)
-
MT Newswires05/20 09:20
-
Yahoo05/19 09:00
-
Yahoo05/18 06:30
-
MT Newswires05/17 09:24
-
Yahoo05/17 08:35
-
Yahoo05/17 08:24
-
MT Newswires05/16 14:35
-
SA Breaking News05/16 12:47
-
Yahoo05/16 09:40
-
MT Newswires05/16 09:26
View All Events
PFE Events
| Date | Type | Description |
|---|---|---|
| 07/31/2019 10:00 EDT | Misc | Pfizer Inc Second Quarter Earnings Conference Call in 2019 |
| 07/31/2019 | Earnings | Pfizer Inc Second Quarter Earnings in 2019 Release |
| 05/09/2019 | Dividends | Amount: 0.36, Declared Date: Apr 25 2019, Pay Date: Jun 07 2019 |
| 04/30/2019 10:00 EDT | Misc | Pfizer Inc First Quarter Earnings Conference Call in 2019 |
| 04/30/2019 | Earnings | Pfizer Inc First Quarter Earnings in 2019 Release |
| 02/28/2019 | Misc | Pfizer Inc Annual Report in 2018 |
| 01/31/2019 | Dividends | Amount: 0.36, Declared Date: Dec 14 2018, Pay Date: Mar 01 2019 |
| 01/29/2019 10:00 EST | Misc | Pfizer Inc Fourth Quarter Earnings Conference Call in 2018 |
| 01/29/2019 | Earnings | Pfizer Inc Fourth Quarter Earnings Results in 2018 |
| 11/08/2018 | Dividends | Amount: 0.34, Declared Date: Sep 27 2018, Pay Date: Dec 03 2018 |
PFE Fundamentals
Income Statement View Statement
PFE Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
PFE One Page Reports
- One Page Report Download
PFE Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 41.36 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.pfizer.com
- Investor Relations URL: http://www.pfizer.com/investors
- HQ State/Province: New York
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Value
- Next Earnings Release: Jul. 31, 2019
- Last Earnings Release: Apr. 30, 2019
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: May. 09, 2019
- Description: Pfizer is one of the world's largest pharmaceutical firms, with annual sales over $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, neuroscience drug Lyrica, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drugs Enbrel and Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor, representing over a fifth of total company sales.
Excel Add-In Codes
- Name: =YCI("PFE","name")
- Description: =YCI("PFE","description")
- Sector: =YCI("PFE","sector")
- Industry: =YCI("PFE","industry")
- Est. Current Fiscal Year End: =YCI("PFE","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other PFE Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- PFE Tweets Stocktwits
Advertisement
